Autologous hemoderivative cancer vaccine (PharmaBlood)

N/A

Report date: 2023/06/26 09:15:22

Base Information

Drug NameAutologous hemoderivative cancer vaccine (PharmaBlood)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPharmablood
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmablood
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A